Literature DB >> 16813950

Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain.

Gaurav Mukerji1, Yiangos Yiangou, Sanjiv K Agarwal, Praveen Anand.   

Abstract

PURPOSE: Painful bladder syndrome is a chronic, debilitating bladder hypersensitivity disorder characterized by urinary frequency, urgency and bladder pain without an identifiable cause. Recent advances in understanding the molecular basis of hypersensitivity provide an opportunity to advance the understanding of and treatment for painful bladder syndrome. We studied the heat and capsaicin receptor transient receptor potential vanilloid receptor subtype 1 in the bladder in patients with painful bladder syndrome and their relationship to pain symptoms.
MATERIALS AND METHODS: Bladder biopsies were obtained from 20 characterized subjects with painful bladder syndrome and 25 with asymptomatic microscopic hematuria as controls. Specimens were immunostained using specific antibodies to transient receptor potential vanilloid receptor subtype 1 and neurofilaments as a structural maker. Nerve fiber and urothelial staining were quantified with computerized image analysis. The results of immunohistochemistry were correlated with the pain score.
RESULTS: There was a marked increase in suburothelial nerve fibers expressing transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome in comparison with that in controls (p <0.0001). The ratio of transient receptor potential vanilloid receptor subtype 1 fibers to neurofilaments was also significantly increased in painful bladder syndrome, suggesting over expression of transient receptor potential vanilloid receptor subtype 1 (p <0.0001). When all specimens studied were included, the pain score correlated significantly with the relative nerve fiber density of transient receptor potential vanilloid receptor subtype 1 in the suburothelium (r = 0.6862, p = 0.0002) as well as the ratio of transient receptor potential vanilloid receptor subtype 1 fibers to neurofilaments (r = 0.5554, p = 0.004). Urothelial transient receptor potential vanilloid receptor subtype 1 showed a tendency toward an increase in the painful bladder syndrome group but it did not achieve statistical significance. No correlation was found between transient receptor potential vanilloid receptor subtype 1 immunoreactivity of urothelium or neurofilament fibers and the pain score.
CONCLUSIONS: This study shows increased transient receptor potential vanilloid receptor subtype 1 in nerve fibers of the bladder in painful bladder syndrome and a correlation of the pain score with the relative density of transient receptor potential vanilloid receptor subtype 1 nerve fibers. Transient receptor potential vanilloid receptor subtype 1 may have a role in the pathophysiology of painful bladder syndrome and it is a potential target for novel therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16813950     DOI: 10.1016/j.juro.2006.03.074

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

Review 1.  From urgency to frequency: facts and controversies of TRPs in the lower urinary tract.

Authors:  Roman Skryma; Natalia Prevarskaya; Dimitra Gkika; Yaroslav Shuba
Journal:  Nat Rev Urol       Date:  2011-10-04       Impact factor: 14.432

Review 2.  TRP channels in lower urinary tract dysfunction.

Authors:  J Franken; P Uvin; D De Ridder; T Voets
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 3.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

4.  Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men.

Authors:  Prasarn Manitpisitkul; Arthur Mayorga; Kevin Shalayda; Marc De Meulder; Gary Romano; Chen Jun; John A Moyer
Journal:  Clin Drug Investig       Date:  2015-06       Impact factor: 2.859

Review 5.  TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulation.

Authors:  Peter M Blumberg; Larry V Pearce; Jeewoo Lee
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 6.  Visceral analgesics: drugs with a great potential in functional disorders?

Authors:  Sylvie Bradesi; Jeremy Herman; Emeran A Mayer
Journal:  Curr Opin Pharmacol       Date:  2008-09-26       Impact factor: 5.547

Review 7.  TRPs in bladder diseases.

Authors:  Lori A Birder
Journal:  Biochim Biophys Acta       Date:  2007-04-20

8.  Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study.

Authors:  Ana Charrua; Rui Pinto; Anna Taylor; André Canelas; Alfredo Ribeiro-da-Silva; Célia D Cruz; Lori Ann Birder; Francisco Cruz
Journal:  Neurourol Urodyn       Date:  2013-12-24       Impact factor: 2.696

9.  Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice.

Authors:  Juan M Jimenez-Andrade; Patrick W Mantyh
Journal:  Arthritis Res Ther       Date:  2012-05-01       Impact factor: 5.156

Review 10.  From interstitial cystitis to chronic pelvic pain.

Authors:  C Persu; V Cauni; S Gutue; Irina Blaj; V Jinga; P Geavlete
Journal:  J Med Life       Date:  2010 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.